Oelisoa Mireille Andriankaja
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Periodontal Diseases | 4 | 2012 | 49 | 1.020 |
Why?
|
| Gingivitis | 2 | 2018 | 7 | 0.980 |
Why?
|
| Periodontitis | 6 | 2017 | 53 | 0.940 |
Why?
|
| Myocardial Infarction | 3 | 2011 | 225 | 0.800 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 26 | 0.670 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 27 | 0.670 |
Why?
|
| Blood Glucose | 2 | 2019 | 353 | 0.660 |
Why?
|
| Tooth | 1 | 2018 | 12 | 0.640 |
Why?
|
| Overweight | 3 | 2019 | 247 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2016 | 643 | 0.580 |
Why?
|
| Insulin Resistance | 1 | 2018 | 184 | 0.550 |
Why?
|
| Obesity | 4 | 2019 | 1067 | 0.510 |
Why?
|
| Periodontal Pocket | 2 | 2011 | 6 | 0.490 |
Why?
|
| Periodontium | 1 | 2012 | 2 | 0.440 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 885 | 0.400 |
Why?
|
| Middle Aged | 14 | 2019 | 10129 | 0.390 |
Why?
|
| Inflammation | 4 | 2018 | 618 | 0.380 |
Why?
|
| Aged | 9 | 2019 | 6741 | 0.380 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 123 | 0.300 |
Why?
|
| Adult | 11 | 2019 | 11712 | 0.290 |
Why?
|
| Smoking | 3 | 2010 | 940 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1015 | 0.290 |
Why?
|
| Periodontal Index | 3 | 2017 | 10 | 0.280 |
Why?
|
| Coronary Disease | 1 | 2006 | 124 | 0.260 |
Why?
|
| Alveolar Bone Loss | 3 | 2013 | 18 | 0.250 |
Why?
|
| Lipid Peroxidation | 2 | 2016 | 140 | 0.230 |
Why?
|
| Male | 12 | 2019 | 20025 | 0.230 |
Why?
|
| Humans | 16 | 2019 | 37093 | 0.210 |
Why?
|
| Periodontal Attachment Loss | 3 | 2016 | 8 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2016 | 356 | 0.190 |
Why?
|
| Female | 11 | 2019 | 20969 | 0.190 |
Why?
|
| Cross-Sectional Studies | 5 | 2017 | 2721 | 0.180 |
Why?
|
| Adiposity | 2 | 2019 | 154 | 0.180 |
Why?
|
| Blood Specimen Collection | 1 | 2019 | 12 | 0.170 |
Why?
|
| Reference Standards | 1 | 2019 | 52 | 0.170 |
Why?
|
| Risk Factors | 4 | 2019 | 3562 | 0.170 |
Why?
|
| Hypertension | 2 | 2019 | 796 | 0.160 |
Why?
|
| Prediabetic State | 1 | 2019 | 53 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 400 | 0.150 |
Why?
|
| Rats, Wistar | 3 | 2012 | 233 | 0.150 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 42 | 0.140 |
Why?
|
| Case-Control Studies | 2 | 2011 | 1130 | 0.140 |
Why?
|
| Dyslipidemias | 1 | 2016 | 43 | 0.130 |
Why?
|
| Glucose Tolerance Test | 2 | 2017 | 68 | 0.130 |
Why?
|
| Sex Factors | 2 | 2010 | 898 | 0.130 |
Why?
|
| Actinobacillus Infections | 2 | 2012 | 3 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2019 | 646 | 0.130 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 149 | 0.120 |
Why?
|
| Rats | 5 | 2013 | 3483 | 0.120 |
Why?
|
| Porphyromonas gingivalis | 2 | 2011 | 32 | 0.120 |
Why?
|
| Lipids | 1 | 2015 | 235 | 0.120 |
Why?
|
| Pasteurellaceae Infections | 1 | 2013 | 1 | 0.120 |
Why?
|
| Gingival Crevicular Fluid | 2 | 2012 | 2 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2013 | 90 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 21 | 0.110 |
Why?
|
| Metabolome | 1 | 2012 | 53 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2013 | 94 | 0.110 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 84 | 0.100 |
Why?
|
| Aggressive Periodontitis | 1 | 2012 | 2 | 0.100 |
Why?
|
| Interleukin-6 | 2 | 2012 | 153 | 0.100 |
Why?
|
| Asthma | 1 | 2016 | 380 | 0.100 |
Why?
|
| Prevotella intermedia | 1 | 2011 | 1 | 0.100 |
Why?
|
| Campylobacter rectus | 1 | 2011 | 1 | 0.100 |
Why?
|
| Campylobacter Infections | 1 | 2011 | 7 | 0.100 |
Why?
|
| Bacteroidaceae Infections | 1 | 2011 | 6 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2012 | 207 | 0.100 |
Why?
|
| Models, Animal | 1 | 2011 | 134 | 0.100 |
Why?
|
| Fusobacterium nucleatum | 1 | 2011 | 8 | 0.100 |
Why?
|
| Fusobacterium Infections | 1 | 2011 | 7 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2011 | 149 | 0.100 |
Why?
|
| Hypertriglyceridemia | 1 | 2010 | 14 | 0.090 |
Why?
|
| Obesity, Abdominal | 1 | 2010 | 30 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 1371 | 0.090 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 97 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 252 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 186 | 0.090 |
Why?
|
| Homeostasis | 1 | 2011 | 188 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2010 | 55 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2011 | 534 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 583 | 0.090 |
Why?
|
| Dental Plaque | 1 | 2009 | 14 | 0.080 |
Why?
|
| Educational Status | 1 | 2010 | 313 | 0.080 |
Why?
|
| Dinoprostone | 1 | 2009 | 63 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 626 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 70 | 0.080 |
Why?
|
| Mexican Americans | 1 | 2010 | 189 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1207 | 0.080 |
Why?
|
| Apoptosis | 2 | 2013 | 1398 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 284 | 0.080 |
Why?
|
| New York | 1 | 2007 | 71 | 0.080 |
Why?
|
| Age Factors | 1 | 2010 | 1033 | 0.070 |
Why?
|
| Biofilms | 1 | 2009 | 168 | 0.070 |
Why?
|
| Alveolar Process | 1 | 2006 | 3 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 485 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2006 | 49 | 0.070 |
Why?
|
| Tooth Loss | 1 | 2006 | 35 | 0.070 |
Why?
|
| Animals | 5 | 2013 | 15081 | 0.070 |
Why?
|
| Waist Circumference | 2 | 2019 | 89 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 2379 | 0.060 |
Why?
|
| Osteoclasts | 2 | 2013 | 14 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2019 | 854 | 0.050 |
Why?
|
| Antibodies, Bacterial | 2 | 2012 | 109 | 0.050 |
Why?
|
| United States | 1 | 2010 | 4223 | 0.050 |
Why?
|
| Young Adult | 1 | 2010 | 4268 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 42 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 61 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 52 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2012 | 352 | 0.040 |
Why?
|
| Dental Plaque Index | 1 | 2016 | 5 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2019 | 1378 | 0.030 |
Why?
|
| Antioxidants | 1 | 2016 | 416 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 664 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 602 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2012 | 41 | 0.030 |
Why?
|
| Epithelial Attachment | 1 | 2012 | 2 | 0.030 |
Why?
|
| Neutrophil Activation | 1 | 2012 | 4 | 0.030 |
Why?
|
| Kanamycin | 1 | 2012 | 5 | 0.030 |
Why?
|
| Ampicillin | 1 | 2012 | 6 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 22 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2012 | 37 | 0.030 |
Why?
|
| Ligation | 1 | 2011 | 10 | 0.030 |
Why?
|
| Treponema denticola | 1 | 2011 | 5 | 0.030 |
Why?
|
| Bacteroides | 1 | 2011 | 8 | 0.030 |
Why?
|
| Injections | 1 | 2011 | 35 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 2011 | 133 | 0.030 |
Why?
|
| Mandible | 1 | 2011 | 17 | 0.030 |
Why?
|
| Skull | 1 | 2011 | 35 | 0.030 |
Why?
|
| Immunization | 1 | 2011 | 92 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 168 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 224 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 455 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 159 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 237 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 938 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 220 | 0.020 |
Why?
|
| Monocytes | 1 | 2012 | 257 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 236 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1742 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 5913 | 0.010 |
Why?
|